Clinical Trial: Fatty Liver Disease Collaborative Research in China
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]
Official Title: A Multi-center, Prospective Cohort Study on the Natural History of Fatty Liver Disease in China
Brief Summary: A multi-center, prospective cohort study on the natural history of fatty liver disease in China
Detailed Summary: This is a multicenter, prospective and open-enrollment epidemiologic study. All the patients with liver biopsy-proven macrovesicular steatosis (>5%) will be enrolled in the baseline cross-sectional analysis. Those who are either diagnosed as NAFLD or ALD, if meeting all the inclusion and exclusion criteria, will be enrolled in the following cohort study, will be followed up after 1 year, 3 years and 5 years with a visit window of +1 month.
Sponsor: Fatty Liver and Alcoholic Liver Disease Study Group, China
Current Primary Outcome: liver cirrhosis [ Time Frame: 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- liver cancer [ Time Frame: 5 years ]
- liver failure [ Time Frame: 5 years ]
- type 2 diabetes [ Time Frame: 5 years ]
- cardiovascular and cerebrovascular events [ Time Frame: 5 years ]
- death [ Time Frame: 5 years ]
Original Secondary Outcome: Same as current
Information By: Fatty Liver and Alcoholic Liver Disease Study Group, China
Dates:
Date Received: March 12, 2015
Date Started: July 2015
Date Completion: December 2020
Last Updated: August 3, 2015
Last Verified: August 2015
